-
•
monitoring of national and European calls for proposals and support in preparing collaborative projects at the national and European level ( Alps Bio Cluster, JADE project, INNOVAge project, IDeAll and TN_G project)
•
website and e-newsletter
Legal framework Association according to the 1901 law (Non-profit organization)
-
Financial framework: •
Membership fee
•
Grants from local authorities and from EU (collaborative projects)
7
Evaluation of the practice
-
Economical development contribution to the territory and the companies: weight of the bio industry sector (number of employees, turnover), sub sectors segmentation, growth of the companies from start ups to SME’s size
-
Market access: Transformation rate (networking/ collaborative projects), number of member companies taken part in European projects, time to go to market, business generated, Medic@lps organized 123 events since 2000
-
Our current indicator is limited to the measurement of the satisfaction of our members
8
-
-
Criteria for evaluation (Aspiration list)
Transferability: Medic@lps with its experience in the health sector for over 12 years has multiple transferability levels from generic ones (emergence, stakeholders federation and animation, interclustering, international development) to tailored ones (international market access support, summer school, etc.). Feedback into policy: Contribution to the Green Paper “From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation funding” – 20th May 2011. How could MEDIC@LPS (formerly ADEBAG) contribute to the achievement of EUROPE 2020? MEDIC@LPS (formerly ADEBAG) with its acute knowledge of the biotech/medtech ecosystem in Grenoble area and its close interaction with its SMEs could not only inform actors on European projects but: •
support them to maximize the return on investment of their implication in European projects;
•
help them in the day-to-day intercultural management of these projects;
•
integrate European projects run by its members in the e-Care Living lab approach.
63